# BeatO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beato

- Industry: Healthcare IT
- Headquarters: New Delhi, India
- Website: www.beatoapp.com
- Total disclosed funding: $43M
- Latest round: Series B (Nov 16, 2022)
- Investors on record: 10

## About

Founded in 2015 and based in New Delhi, India, Health Arx Technologies Pvt. Ltd., doing business as BeatO, operates as a developer of a mobile application that motivates and assists diabetic individuals in the management of their condition. The company was founded by its CEO Gautam Chopra, Yash Sehgal, and Abhishek Kumar. In February 2021, Health Arx Technologies Pvt. Ltd. raised INR 35 million in venture debt funding from new investor Alteria Capital.

The company also provides a medical device, smartphone glucometers that detect the level of glucose in a person's blood. The company’s diabetes care and management mobile application syncs with the glucometer when it's connected to the smartphone and allows users to take sugar readings and maintain a log of all the previous readings to help the doctors monitor their medications. The device is available in two variants: glucometer kit and curv glucometer kit that comes with 50 strips and 50 lancets both priced INR 2400. The company also has an e-commerce service on its website and mobile application that allows users to buy medicines, healthy food items, detox drinks, ayurvedic products, and lab tests. 

The company's operating revenue for the financial year that ended on 31 March 2020 ranged from INR 1 crore- 100 crore and Its EBITDA decreased by -12.07 % compared to the previous year. In the same financial year, Health Arx Technologies' book net worth increased by 97.20 %.

## Funding rounds

- Series B, Nov 16, 2022, $33M — Leo Capital Holdings, Blume Ventures, Lightrock, Orios Venture Partners, HealthQuad, Flipkart Venture Fund, W Health Ventures
- Series B, Jun 29, 2021, $5.6M — Leo Capital Holdings, Orios Venture Partners, Merisis Advisors, PharmEasy, W Health Ventures
- Series A, Sep 5, 2019, $4.3M — Leo Capital Holdings, Vistra ITCL

## Investors

- Leo Capital Holdings (https://capitalatlas.ai/funds/leo-capital-holdings) — Series A, Series B
- Vistra ITCL — Series A
- Orios Venture Partners (https://capitalatlas.ai/funds/orios-venture-partners) — Series B
- Merisis Advisors — Series B
- PharmEasy — Series B
- W Health Ventures (https://capitalatlas.ai/funds/w-health-ventures) — Series B
- Blume Ventures (https://capitalatlas.ai/funds/blume-ventures) — Series B
- Lightrock (https://capitalatlas.ai/funds/lightrock) — Series B
- HealthQuad (https://capitalatlas.ai/funds/healthquad) — Series B
- Flipkart Venture Fund (https://capitalatlas.ai/funds/flipkart-venture-fund) — Series B